Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cogane (PYM50028) in Early-Stage Parkinson's Disease
DRKS00000756Phase 2Completed
- Sponsor
- Phytopharm plc
- Start
- May 2011
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 10
01
Overview
Phase 2, randomised, double-blind trial of smilagenin in Parkinson's disease (PD) (4 arms), sponsored by Phytopharm plc. Started May 2011; status: completed.
02
Drugs
smilagenin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on DRKS00000756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000756.